-       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                  -       Clinical Trials 
   - April 2025
    -  80 Pages 
    Global
   
   From       €1438EUR$1,600USD£1,261GBP 
      €1798EUR$2,000USD£1,577GBP 
                  -       Drug Pipelines 
   - April 2025
    -  80 Pages 
    Global
   
   From       €1079EUR$1,200USD£946GBP 
      €1348EUR$1,500USD£1,182GBP 
                  -       Drug Pipelines 
   - April 2025
    -  60 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                   -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €899EUR$1,000USD£788GBP 
      €1124EUR$1,250USD£985GBP 
                  -       Report 
   - May 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                -       Report 
   - February 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €1079EUR$1,200USD£946GBP 
      €1348EUR$1,500USD£1,182GBP 
                  -       Clinical Trials 
   - April 2025
    -  80 Pages 
    Global
   
   From       €1438EUR$1,600USD£1,261GBP 
      €1798EUR$2,000USD£1,577GBP 
                -       Report 
   - January 2025
    -  175 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                  -       Report 
   - June 2024
    -  200 Pages 
    Global
   
   From       €5716EUR$6,360USD£5,013GBP 
      €7146EUR$7,950USD£6,267GBP 
                  -       Report 
   - May 2024
    -  137 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                -       Report 
   - April 2024
    -  72 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - November 2024
    -  88 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
             
         Adenosine is a drug used in the treatment of endocrine and metabolic disorders. It is a purine nucleoside that acts as a neuromodulator, regulating the activity of various neurotransmitters and hormones. Adenosine is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to treat certain types of heart failure, as well as to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms.
Adenosine    is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms, and is often prescribed in combination with other drugs.
Some companies in the Adenosine market include Novartis, Merck, Pfizer, Sanofi, and GlaxoSmithKline. Show Less   Read more